{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:20:27Z","timestamp":1779344427699,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.clnu.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:13:50Z","timestamp":1677014030000},"page":"467-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8207-0149","authenticated-orcid":false,"given":"Jiudan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-3282","authenticated-orcid":false,"given":"Sylva Mareike","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1792-1757","authenticated-orcid":false,"given":"Stefan","family":"Kabisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Csanalosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-8726","authenticated-orcid":false,"given":"Bettina","family":"Schuppelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margrit","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya","family":"Markova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8208-0061","authenticated-orcid":false,"given":"Nina Marie Tosca","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-8546","authenticated-orcid":false,"given":"Olga","family":"Pivovarova-Ramich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Keyhani-Nejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-8830","authenticated-orcid":false,"given":"Sascha","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-0016","authenticated-orcid":false,"given":"Andreas F.H.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnu.2023.02.011_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.clnu.2023.02.011_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJM197007162830301","article-title":"Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion","volume":"283","author":"Muller","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.clnu.2023.02.011_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2011-1499","article-title":"Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes","volume":"153","author":"Cryer","year":"2012","journal-title":"Endocrinology"},{"issue":"37","key":"10.1016\/j.clnu.2023.02.011_bib4","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1073\/pnas.1006639107","article-title":"Paracrinology of islets and the paracrinopathy of diabetes","volume":"107","author":"Unger","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2337\/dbi19-0004","article-title":"Repositioning glucagon action in the physiology and pharmacology of diabetes","volume":"69","author":"Finan","year":"2020","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/diabetes.55.04.06.db05-1449","article-title":"Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis","volume":"55","author":"Meier","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2023.02.011_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2019.04.014","article-title":"The incretin system in healthy humans: the role of GIP and GLP-1","volume":"96","author":"Holst","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.clnu.2023.02.011_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","article-title":"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2023.02.011_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1463-1326.2011.01452.x","article-title":"Regulation of glucagon secretion by incretins","volume":"13","author":"Holst","year":"2011","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.clnu.2023.02.011_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2023.02.011_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170213","article-title":"The role of GIP in alpha-cells and glucagon secretion","volume":"125","author":"El","year":"2020","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.clnu.2023.02.011_bib12","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/db11-0979","article-title":"Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans","volume":"60","author":"Christensen","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.clnu.2023.02.011_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-003-1103-y","article-title":"Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia","volume":"46","author":"Meier","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db10-1332","article-title":"GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes","volume":"60","author":"Mentis","year":"2011","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.clnu.2023.02.011_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1948","article-title":"GIP mediates the incretin effect and glucose tolerance by dual actions on alpha cells and beta cells","volume":"7","author":"El","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.clnu.2023.02.011_bib16","article-title":"Intra-islet glucagon signaling is critical for maintaining glucose homeostasis","volume":"5","author":"Zhu","year":"2019","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.clnu.2023.02.011_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129954","article-title":"Glucagon lowers glycemia when beta-cells are active","volume":"5","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126742","article-title":"Beta Cell tone is defined by proglucagon peptides through cAMP signaling","volume":"4","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.clnu.2023.02.011_bib20","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1007\/s00125-020-05196-3","article-title":"Alpha cell regulation of beta cell function","volume":"63","author":"Moede","year":"2020","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib21","doi-asserted-by":"crossref","first-page":"E791","DOI":"10.1210\/jc.2011-3439","article-title":"Impaired crosstalk between pulsatile insulin and glucagon secretion in prediabetic individuals","volume":"97","author":"Rohrer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clnu.2023.02.011_bib22","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2337\/db11-0251","article-title":"Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes","volume":"60","author":"Menge","year":"2011","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.clnu.2023.02.011_bib23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-014-3264-2","article-title":"Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals","volume":"57","author":"Bagger","year":"2014","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00125-007-0598-z","article-title":"Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects","volume":"50","author":"Meier","year":"2007","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.clnu.2023.02.011_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41467-018-08193-8","article-title":"Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion","volume":"10","author":"Vergari","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.clnu.2023.02.011_bib26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cmet.2018.10.003","article-title":"Dysregulation of glucagon secretion by hyperglycemia-induced sodium-dependent reduction of ATP production","volume":"29","author":"Knudsen","year":"2019","journal-title":"Cell Metabol"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diabetes.53.4.1038","article-title":"Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells","volume":"53","author":"Wendt","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2009.02.007","article-title":"Insulin signaling in alpha cells modulates glucagon secretion in\u00a0vivo","volume":"9","author":"Kawamori","year":"2009","journal-title":"Cell Metabol"},{"issue":"12","key":"10.1016\/j.clnu.2023.02.011_bib29","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.celrep.2016.11.072","article-title":"Human beta cells produce and release serotonin to inhibit glucagon secretion from alpha cells","volume":"17","author":"Almaca","year":"2016","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.clnu.2023.02.011_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cmet.2013.10.014","article-title":"Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metabol"},{"issue":"6","key":"10.1016\/j.clnu.2023.02.011_bib31","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00665.2010","article-title":"The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes","volume":"300","author":"Lund","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2337\/db18-1138","article-title":"Postprandial aminogenic insulin and glucagon secretion can stimulate glucose flux in humans","volume":"68","author":"Ang","year":"2019","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.clnu.2023.02.011_bib33","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1172\/JCI107046","article-title":"Glucagon-stimulating activity of 20 amino acids in dogs","volume":"51","author":"Rocha","year":"1972","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.clnu.2023.02.011_bib34","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI105916","article-title":"Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids","volume":"47","author":"Ohneda","year":"1968","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.clnu.2023.02.011_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajcn\/nqy100","article-title":"Rate of appearance of amino acids after a meal regulates insulin and glucagon secretion in patients with type 2 diabetes: a randomized clinical trial","volume":"108","author":"Markova","year":"2018","journal-title":"Am J Clin Nutr"},{"issue":"20","key":"10.1016\/j.clnu.2023.02.011_bib36","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1016\/S0021-9258(18)63619-1","article-title":"Effects of glucagon on amino acid transport and utilization in the perfused rat liver","volume":"244","author":"Mallette","year":"1969","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/er.2018-00251","article-title":"The liver-alpha-cell Axis and type 2 diabetes","volume":"40","author":"Wewer Albrechtsen","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/dbi19-0021","article-title":"A\u00a0primary role for alpha-cells as amino acid sensors","volume":"69","author":"Dean","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2023.02.011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170225","article-title":"Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates","volume":"125","author":"Knerr","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.clnu.2023.02.011_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fendo.2019.00144","article-title":"Impact of nutrient type and sequence on glucose tolerance: physiological insights and therapeutic implications","volume":"10","author":"Nesti","year":"2019","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.clnu.2023.02.011_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clnu.2023.02.011_bib42","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2337\/dc15-1891","article-title":"Effects of palatinose and sucrose intake on glucose metabolism and incretin secretion in subjects with type 2 diabetes","volume":"39","author":"Keyhani-Nejad","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2023.02.011_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170231","article-title":"Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction","volume":"125","author":"Keyhani-Nejad","year":"2020","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.clnu.2023.02.011_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tem.2018.03.003","article-title":"High glycemic index metabolic damage - a pivotal role of GIP and GLP-1","volume":"29","author":"Pfeiffer","year":"2018","journal-title":"Trends Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.clnu.2023.02.011_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jdiacomp.2014.12.010","article-title":"Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients","volume":"29","author":"Yabe","year":"2015","journal-title":"J\u00a0Diabet Complicat"},{"issue":"26","key":"10.1016\/j.clnu.2023.02.011_bib46","doi-asserted-by":"crossref","first-page":"14930","DOI":"10.1073\/pnas.94.26.14930","article-title":"Slow and fast dietary proteins differently modulate postprandial protein accretion","volume":"94","author":"Boirie","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.clnu.2023.02.011_bib47","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.90233.2008","article-title":"Incretin and islet hormonal responses to fat and protein ingestion in healthy men","volume":"295","author":"Carr","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.clnu.2023.02.011_bib48","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1113\/JP279775","article-title":"Resistance is futile?' - paradoxical inhibitory effects of KATP channel closure in glucagon-secreting alpha-cells","volume":"598","author":"Zhang","year":"2020","journal-title":"J\u00a0Physiol"},{"issue":"1","key":"10.1016\/j.clnu.2023.02.011_bib49","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41467-020-15717-8","article-title":"Paracrine control of alpha-cell glucagon exocytosis is compromised in human type-2 diabetes","volume":"11","author":"Omar-Hmeadi","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.clnu.2023.02.011_bib50","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00125-019-4956-4","article-title":"A\u00a0carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial","volume":"62","author":"Skytte","year":"2019","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.clnu.2023.02.011_bib51","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/liv.14596","article-title":"High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2023.02.011_bib52","doi-asserted-by":"crossref","first-page":"808346","DOI":"10.3389\/fnut.2022.808346","article-title":"High protein diets improve liver fat and insulin sensitivity by prandial but not fasting glucagon secretion in type 2 diabetes","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:10:22Z","timestamp":1759367422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0261561423000407"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.02.011","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}